ID   RSBS-43
AC   CVCL_C8X6
DR   Wikidata; Q123033387
RX   PubMed=29609538;
RX   PubMed=35692560;
CC   Population: Indian.
CC   Doubling time: ~48 hours (PubMed=29609538).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
RX   PubMed=29609538; DOI=10.1186/s12885-018-4237-5; PMCID=PMC5879557;
RA   Javed, Shifa
RA   Sharma, Bal Krishan
RA   Sood, Swati
RA   Sharma, Sanjeev
RA   Bagga, Rashmi
RA   Bhattacharyya, Shalmoli
RA   Rayat, Charan Singh
RA   Dhaliwal, Lakhbir
RA   Srinivasan, Radhika
RT   "Significance of CD133 positive cells in four novel HPV-16 positive
RT   cervical cancer-derived cell lines and biopsies of invasive cervical
RT   cancer.";
RL   BMC Cancer 18:357.1-357.12(2018).
//
RX   PubMed=35692560; DOI=10.1080/23723556.2022.2078628; PMCID=PMC9176225;
RA   de Lourdes Zuniga-Martinez, Ma
RA   Lopez-Mendoza, Carlos Miguel
RA   Tenorio-Salazar, Jared
RA   Garcia-Carranca, Alejandro Manuel
RA   Cerbon-Cervantes, Marco Antonio
RA   Alcantara-Quintana, Luz Eugenia
RT   "Establishment, authenticity, and characterization of cervical cancer
RT   cell lines.";
RL   Mol. Cell. Oncol. 9:2078628.1-2078628.10(2022).
//